← FDA DRUG APPROVALS

FDA ANDA · ANDA088891

ERGOLOID MESYLATES

Sponsor: MUTUAL PHARM

APPLICATION
ANDA088891
TYPE
ANDA
ORIGINAL APPROVAL
1985-11-01
LATEST ACTION
1998-12-01
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

ERGOLOID MESYLATESDiscontinued
ERGOLOID MESYLATES 1MG · TABLET · ORAL

Approval history

1998-12-01Manufacturing (CMC) · Supplement 16AP
1994-12-23Manufacturing (CMC) · Supplement 15AP
1994-10-11Manufacturing (CMC) · Supplement 14AP
1992-04-03Manufacturing (CMC) · Supplement 13AP
1992-04-03Manufacturing (CMC) · Supplement 11AP
1989-04-10Labeling · Supplement 9AP
1988-09-08Labeling · Supplement 10AP
1987-06-05Manufacturing (CMC) · Supplement 5AP
1987-04-03Manufacturing (CMC) · Supplement 7AP
1985-11-01OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →